跳至主要内容
临床试验/NCT02055261
NCT02055261已完成1 期

Effects of Low Frequency Deep Brain Stimulation of the Pedunculopontine Nucleus on Gait and Balance Disorders of Parkinson's Disease

Pitié-Salpêtrière Hospital2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2009年5月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
6
试验地点
2
主要终点
Change of Rating scale for gait evaluation between 'Off stim off drug" and "On stim off drug" conditions

研究概览

简要总结

The appearance of postural instability and gait disorders is a major turning point in the evolution of Parkinson's disease (PD). These axial symptoms are usually unresponsive to L-Dopa and represent a severe impairment for the patients due to frequent falls and reduced outside mobility. There is no effective pharmacological treatment available for these symptoms, and their pathophysiology is not well known : it is currently assumed that non-dopaminergic brainstem lesions participate to axial symptoms in PD. Surgically, these patients cannot benefit from high frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) since this operation tends to even aggravate axial symptoms unresponsive to L-Dopa in some patients. A dysfunction of the pedunculopontine nucleus (PPN) might be at the origin of these axial symptoms, since the PPN participates in the maintenance of posture and motion in primates. In PD patients, recent reports have suggested that low frequency stimulation of the PPN may equally improve gait and posture. However, these results are debatable due to methodological limitations, insufficient clinical evaluation and uncertain anatomical targeting. Thus, our aim is to propose a low frequency PPN stimulation to six advanced PD patients according to the usual criteria for STN DBS who are, however, unsuitable for this operation due to gait and posture disorders. We will perform a randomized, double-blind and cross over design (two months periods with and without DBS randomly assigned to each patient). The targeting will be allowed by a a three-dimensional and deformable atlas of the basal ganglia fusioned with the stereotaxic magnetic resonance imaging (MRI) of each patient. Evaluations will comprise 1 month before surgery and in "Off" and "On" stimulation condition:

  • clinical motor assessment in both "Off" and "On" drug state, including cardinal parkinsonian signs, gait and balance
  • gait initiation physiological evaluation
  • cognitive and behavioral testing If our hypothesis is confirmed, low frequency PPN stimulation may well represent a substantial improvement of our therapeutic options for advanced PD patients suffering from debilitating gait and posture disorders unresponsive to L-Dopa.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Parkinson's disease
  • Age < 70 and > = 18 years
  • Improvement > or = 50 % during acute levodopa test
  • Score > or = 2 on item 29 of UPDRS part 3 score obtained in "off" drug state
  • No previous DBS
  • No evidence of atypical parkinsonism
  • No dementia (MATTIS > 129)
  • No psychiatric disease
  • Contraception if woman
  • Informed consent

排除标准

  • Contra indication to surgery
  • Contra indication to MRI
  • Severe life threatening comorbidity

结局指标

主要结局

Change of Rating scale for gait evaluation between 'Off stim off drug" and "On stim off drug" conditions

时间窗: 4 months and 6 months after surgery

The primary outcome criteria will be the comparison between RSGE total score in obtained 'Off' and 'On' stimulation conditions either at 4 or 6 months after surgery according to the randomized order of the cross-over

次要结局

  • Adverse events records(1 month before surgery, 1-2-3-4-5-6 months after surgery)
  • Change of UPDRS part 3 score between "Off Stim On drug" and "No stim On drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of Rating scale for gait evaluation between 'On stim Off drug" and "No stim off drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of Rating scale for gait evaluation between 'On stim On drug" and "No stim On drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of gait physiological parameters between "Off Stim Off drug" and "ON stim Off drug" conditions(4 and 6 months after surgery)
  • Change of UPDRS part 3 score between "Off Stim Off drug" and "ON stim Off drug" conditions(4 and 6 months after surgery)
  • Change of Rating scale for gait evaluation between 'Off stim on drug" and "On stim on drug" conditions(4 and 6 months after surgery)
  • Change of UPDRS part 3 score between "Off Stim On drug" and "ON stim On drug" conditions(4 and 6 months after surgery)
  • Change of UPDRS part 3 score between "Off Stim Off drug" and "No stim Off drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of Rating scale for gait evaluation between 'Off stim Off drug" and "No stim off drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of Rating scale for gait evaluation between 'Off stim On drug" and "No stim on drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of gait physiological parameters between "Off Stim On drug" and "ON stim On drug" conditions(4 and 6 months after surgery)
  • Change of gait physiological parameters between "No Stim On drug" and "Off stim On drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of gait physiological parameters between "No Stim Off drug" and "On stim off drug" conditions(1 month before surgery and 4 or 6 months after surgery)
  • Change of gait physiological parameters between "No Stim Off drug" and "Off stim off drug" conditions(1 month before surgery and 4 or 6 months after surgery)

研究者

发起方
Pitié-Salpêtrière Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

David Grabli

MD PhD

Pitié-Salpêtrière Hospital

研究点 (2)

Loading locations...

相似试验

Pedunculopontine Nucleus Stimulation for Gait... | 临床试验